AMENDMENT NO. 3 TO PROMISSORY NOTE OF FLUOROPHARMA MEDICAL, INC.Fluoropharma Medical, Inc. • July 27th, 2016 • In vitro & in vivo diagnostic substances • New York
THIS AMENDMENT NO. 3 TO PROMISSORY NOTE OF FLUOROPHARMA MEDICAL, INC. (this “Amendment”), dated as of July 22, 2016, is made by FluoroPharma Medical, Inc., a Nevada corporation (the “Company” or the “Borrower”), and the undersigned holders (each, a “Holder” and, collectively, the “Holders”). The Company and the Holders are sometimes referred to individually as “Party” and collectively as the “Parties”.
AMENDMENT NO. 1 TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • July 27th, 2016 • Fluoropharma Medical, Inc. • In vitro & in vivo diagnostic substances • New York
THIS AMENDMENT NO. 1 TO NOTE PURCHASE AGREEMENT by and between FLUOROPHARMA MEDICAL, INC. and one or more Purchasers (this “Amendment”), dated initially as of July 22, 2016, is made by FluoroPharma Medical, Inc., a Nevada corporation (the “Company”), and the undersigned (each, a “Purchaser” and, collectively, the “Purchasers”). The Company and the Purchasers are sometimes referred to individually as “Party” and collectively as the “Parties”.
